Theranostics Targeting Fibroblast Activation Protein in the Tumor Stroma: 64Cu- and 225Ac-Labeled FAPI-04 in Pancreatic Cancer Xenograft Mouse Models
暂无分享,去创建一个
T. Watabe | E. Shimosegawa | J. Hatazawa | U. Haberkorn | F. Giesel | C. Kratochwil | A. Toyoshima | T. Lindner | Yuwei Liu | Kojiro Nagata | A. Shinohara | K. Kaneda-Nakashima | Y. Shirakami | K. Ooe
[1] Maria Filomena Botelho,et al. MIA PaCa-2 and PANC-1 – pancreas ductal adenocarcinoma cell lines with neuroendocrine differentiation and somatostatin receptors , 2016, Scientific Reports.
[2] Long-Bang Chen,et al. Cancer associated fibroblasts: An essential role in the tumor microenvironment , 2017, Oncology letters.
[3] Frederik L. Giesel,et al. 68Ga-FAPI PET/CT: Biodistribution and Preliminary Dosimetry Estimate of 2 DOTA-Containing FAP-Targeting Agents in Patients with Various Cancers , 2018, The Journal of Nuclear Medicine.
[4] Thomas Lindner,et al. Development of Fibroblast Activation Protein–Targeted Radiotracers with Improved Tumor Retention , 2019, The Journal of Nuclear Medicine.
[5] M. Welch,et al. In vivo transchelation of copper-64 from TETA-octreotide to superoxide dismutase in rat liver. , 2000, Bioconjugate chemistry.
[6] E. Cukierman,et al. FAP-overexpressing fibroblasts produce an extracellular matrix that enhances invasive velocity and directionality of pancreatic cancer cells , 2011, BMC Cancer.
[7] P. Choyke,et al. Detection Efficacy of 18F-PSMA-1007 PET/CT in 251 Patients with Biochemical Recurrence of Prostate Cancer After Radical Prostatectomy , 2018, The Journal of Nuclear Medicine.
[8] H. Maecke,et al. The somatostatin receptor 2 antagonist 64Cu-NODAGA-JR11 outperforms 64Cu-DOTA-TATE in a mouse xenograft model , 2018, PloS one.
[9] Z. Cai,et al. Fibroblast activation protein α in tumor microenvironment: Recent progression and implications (Review) , 2015, Molecular medicine reports.
[10] A. Maes,et al. Predictors of Overall and Disease-Free Survival in Metastatic Castration-Resistant Prostate Cancer Patients Receiving 225Ac-PSMA-617 Radioligand Therapy , 2020, The Journal of Nuclear Medicine.
[11] J. Waterton,et al. Acute tumour response to the MEK1/2 inhibitor selumetinib (AZD6244, ARRY-142886) evaluated by non-invasive diffusion-weighted MRI , 2013, British Journal of Cancer.
[12] W. Weichert,et al. Targeted α-Therapy of Metastatic Castration-Resistant Prostate Cancer with 225Ac-PSMA-617: Dosimetry Estimate and Empiric Dose Finding , 2017, The Journal of Nuclear Medicine.
[13] Thomas Lindner,et al. Development of Quinoline-Based Theranostic Ligands for the Targeting of Fibroblast Activation Protein , 2018, The Journal of Nuclear Medicine.
[14] F. Mottaghy,et al. 225Ac-PSMA-617 for PSMA-Targeted α-Radiation Therapy of Metastatic Castration-Resistant Prostate Cancer , 2016, The Journal of Nuclear Medicine.
[15] F. Westwood,et al. Antitumor activity of the novel vascular targeting agent ZD6126 in a panel of tumor models. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.
[16] D. Jäger,et al. A Tumor-Imaging Method Targeting Cancer-Associated Fibroblasts , 2018, The Journal of Nuclear Medicine.
[17] Frederik L. Giesel,et al. 68Ga-FAPI PET/CT: Tracer Uptake in 28 Different Kinds of Cancer , 2019, The Journal of Nuclear Medicine.
[18] C. Apostolidis,et al. Production of Ac-225 from Th-229 for targeted alpha therapy. , 2005, Analytical chemistry.
[19] Eva Forssell-Aronsson,et al. Biodistribution and dosimetry of free 211At, 125I- and 131I- in rats. , 2013, Cancer biotherapy & radiopharmaceuticals.
[20] Fei Xing,et al. Cancer associated fibroblasts (CAFs) in tumor microenvironment. , 2010, Frontiers in bioscience.
[21] Dehai Che,et al. Fibroblast Activation Protein Overexpression and Clinical Implications in Solid Tumors: A Meta-Analysis , 2015, PloS one.
[22] Qinan Bao,et al. Performance Evaluation of the Inveon Dedicated PET Preclinical Tomograph Based on the NEMA NU-4 Standards , 2009, Journal of Nuclear Medicine.
[23] Z. Werb,et al. The Role of Stroma in Tumor Development. , 2015, Cancer journal.